These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33883562)

  • 41. Loss of p27 expression in canine mammary tumors and their metastases.
    Klopfleisch R; Schütze M; Gruber AD
    Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PKM2 in Canine Mammary Tumors: Parallels to Human Breast Cancer.
    Lee HJ; Han HJ; Lee JY; Son WC
    Comp Med; 2020 Aug; 70(4):349-354. PubMed ID: 32718384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down-expression of klotho in canine mammary gland tumors and its prognostic significance.
    Chung H; Lee S; Kim GA; Kim WH
    PLoS One; 2022; 17(6):e0265248. PubMed ID: 35666743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor-associated carbohydrate antigens: Sialyl Lea and T/Tn antigens in canine mammary tumors.
    Nowak M; Madej J; Dziegiel P; Lopuszynski W; Rodo A; Ugorski M
    Vet Pathol; 2009 Mar; 46(2):222-6. PubMed ID: 19261632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
    Gama A; Gärtner F; Alves A; Schmitt F
    Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P-cadherin expression in canine mammary tissues.
    Gama A; Paredes J; Albergaria A; Gartner F; Schmitt F
    J Comp Pathol; 2004 Jan; 130(1):13-20. PubMed ID: 14693120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p62/SQSTM1 expression in canine mammary tumours: Evolutionary notes.
    Mariotti F; Magi GE; Gavazza A; Vincenzetti S; Komissarov A; Shneider A; Venanzi FM
    Vet Comp Oncol; 2019 Dec; 17(4):570-577. PubMed ID: 31332942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
    Ahern TE; Bird RC; Bird AE; Wolfe LG
    Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of immunohistochemical markers of lymphatic and blood vessels in canine mammary tumours.
    Sleeckx N; Van Brantegem L; Fransen E; Van den Eynden G; Casteleyn C; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2013 May; 148(4):307-17. PubMed ID: 23123127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced canine BRCA2 expression levels in mammary gland tumors.
    Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
    BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and Roles of S100A4 in Anaplastic Cells of Canine Mammary Carcinomas.
    Yoshimura H; Otsuka A; Michishita M; Yamamoto M; Ashizawa M; Zushi M; Moriya M; Azakami D; Ochiai K; Matsuda Y; Ishiwata T; Kamiya S; Takahashi K
    Vet Pathol; 2019 May; 56(3):389-398. PubMed ID: 30686112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptomic profile reveals molecular events associated to focal adhesion and invasion in canine mammary gland tumour cell lines.
    Cordeiro YG; Xavier PLP; Rochetti AL; Alexandre PA; Mori CMC; Strefezzi RF; Fukumasu H
    Vet Comp Oncol; 2018 Mar; 16(1):E89-E98. PubMed ID: 28834169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between basal and luminal cytokeratins with histopathologic characteristics of canine mammary gland cancer.
    Eivani D; Mortazavi P
    Pol J Vet Sci; 2016; 19(2):261-9. PubMed ID: 27487499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. L-type amino acid transporter 1 (LAT1) expression in canine mammary gland tumors.
    Fukumoto S; Hanazono K; Komatsu T; Iwano H; Kadosawa T; Uchide T
    J Vet Med Sci; 2013 May; 75(4):431-7. PubMed ID: 23171689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
    de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
    Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of CD44 in canine mammary tumours.
    Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
    J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
    Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
    Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mast cells in canine mammary gland tumour: number, distribution and EPOR positivity.
    Sfacteria A; Lanteri G; Grasso G; Macrì B; Mazzullo G
    Vet Comp Oncol; 2011 Dec; 9(4):310-5. PubMed ID: 22077413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malignant mammary tumor in female dogs: environmental contaminants.
    Andrade FH; Figueiroa FC; Bersano PR; Bissacot DZ; Rocha NS
    Diagn Pathol; 2010 Jun; 5():45. PubMed ID: 20587072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.